Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data | PLOS ONE
RESCATE DE LOS PACIENTES CON HEPATITIS C QUE HAN FALLADO A TERAPIAS BASADAS EN ANTIVIRALES DE ACCIÓN DIRECTA. EXPERIENCIA EN VI
Incremental cost and effectiveness of SOF/VEL relative to SOF/LDV in... | Download Scientific Diagram
Tratamiento de la hepatitis C en el pre- y postrasplante hepático | Gastroenterología y Hepatología
Informe d'avaluació de resultats del tractament antiviral de l'hepatitis C a l'any 2018
Treatment groups by regimen. SOF, sofosbuvir; LDV, ledipasvir; SIM,... | Download Scientific Diagram
Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis - ScienceDirect
Efficacy and tolerability of interferon‑free regimen for patients with genotype‑1 HCV infection
Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C | Anales de Pediatría
Pooling SAE rates of SOFL/LDV regimen on HCV genotype 6. SAE, serious... | Download Scientific Diagram
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study | PLOS ONE
ION-3 Study: LDV/SOF + RBV for naïve genotype 1 - ppt download
Six weeks of sofosbuvir/ledipasvir (SOF/LDV) are sufficient to treat acute hepatitis C virus genotype 1 monoinfection: The HepNet Acute HCV IV Study
EVALUACION DE LA EFICACIA Y SEGURIDAD DE LOS TRATAMIENTOS CON LOS NUEVOS ANTIVIRALES DIRECTOS DEL VHC EN PACIENTES COINFECTADOS
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/ LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV) | Scientific Reports
Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021
Antiviral activity of LDV and SOF as monotherapy (A) and combination... | Download Scientific Diagram
Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b - Zakalashvili - 2021 - Hepatology Research - Wiley Online Library
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
Treatment outcomes for SOF/LDV without RBV for HCV genotype 1 (1a, 1b,... | Download Scientific Diagram
Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C | Hepatitis Monthly | Full Text
Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study | BMJ Open
Incremental cost and effectiveness of SOF/LDV and SOF/VEL relative to... | Download Scientific Diagram
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
